Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study.
Anosmia
COVID-19
Dysguageusia
Loss of smell
Positive predictive value
SARS-CoV-2
Viral load
Journal
The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
14
05
2020
revised:
02
07
2020
accepted:
03
07
2020
pubmed:
11
7
2020
medline:
6
10
2020
entrez:
11
7
2020
Statut:
ppublish
Résumé
To determine the frequency of SARS-CoV-2 positive samples in a subset of patients consulting for primarily isolated acute (<7 days) loss of smell and to assess the diagnostic accuracy of olfactory/gustatory dysfunction for COVID-19 diagnosis in the overall population tested for COVID-19 in the same period. Prospective multicentric cohort study in four olfactory ENT units and a screening center for COVID-19. i) Among a subset of 55 patients consulting for primarily recent loss of smell, we found that 51 (92.7%) had a COVID-19 positive test (median viral load of 28.8 cycle threshold). Loss of smell was mostly total (anosmia), rarely associated with nasal obstruction but associated with a taste disorder in 80%. Olfactory dysfunction occurred suddenly, either as first complaint or preceded by mild symptoms occurring a median of 3 days. The majority of patients (72.9%) partially recovered the sense of smell within 15 days. ii) In a population of 1824 patients tested for COVID-19, the positive predictive value and the specificity of loss of smell and/or taste were 78.5% and 90.3% respectively (sensitivity (40.8%), negative predictive value (63.6%)). Self-reported loss of smell had a high predictive positive value to identify COVID-19. Making this sign well known publicly could help to adopt isolation measures and inform potential contacts.
Identifiants
pubmed: 32650110
pii: S0163-4453(20)30463-1
doi: 10.1016/j.jinf.2020.07.005
pmc: PMC7338860
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
614-620Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of Competing Interest All the authors have read and agreed with the paper's content. No authors have financial or personal conflicts. Neither the work nor any part of its essential substance, tables or figures have been or will be published or submitted to another scientific journal or are being considered for publication elsewhere.
Références
Clin Chem Lab Med. 2020 Jun 25;58(7):1070-1076
pubmed: 32172228
J Med Virol. 2020 Jun;92(6):552-555
pubmed: 32104915
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Rhinology. 2016 Jan 31;56(1):1-30
pubmed: 28623665
Rhinology. 2020 Jun 1;58(3):295-298
pubmed: 32277751
Int Forum Allergy Rhinol. 2020 Aug;10(8):944-950
pubmed: 32301284
Rhinology. 2006 Jun;44(2):135-9
pubmed: 16792173
JAMA. 2020 Feb 25;323(8):707-708
pubmed: 31971553
Crit Care. 2020 Apr 23;24(1):170
pubmed: 32326952
Rhinology. 1994 Sep;32(3):113-8
pubmed: 7530857
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Med Virol. 2020 Jun;92(6):577-583
pubmed: 32162702
Lancet Infect Dis. 2020 Sep;20(9):1014-1015
pubmed: 32304632
Otolaryngol Clin North Am. 2004 Dec;37(6):1159-66
pubmed: 15563908
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Am J Rhinol Allergy. 2014 Sep-Oct;28(5):419-22
pubmed: 25198029
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
pubmed: 32253535
Chem Senses. 2001 Oct;26(8):953-63
pubmed: 11595672
Laryngoscope. 2011 Aug;121(8):1687-701
pubmed: 21792956
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Laryngoscope. 2007 Feb;117(2):272-7
pubmed: 17277621
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
Int Forum Allergy Rhinol. 2020 Jul;10(7):821-831
pubmed: 32329222